Advertisement
Singapore markets closed

  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     

  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • Bitcoin USD

    63,887.04
    -959.57 (-1.48%)
     

  • CMC Crypto 200

    1,332.02
    -64.52 (-4.62%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • Dow

    38,239.66
    +153.86 (+0.40%)
     

  • Nasdaq

    15,927.90
    +316.14 (+2.03%)
     

  • Gold

    2,348.40
    +5.90 (+0.25%)
     

  • Crude Oil

    83.64
    +0.07 (+0.08%)
     

  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     

  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     

  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     

  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Athersys (ATHX) in Focus: Stock Moves 10.22% Higher

Zacks Equity Research
Updated

Athersys, Inc.ATHX was a big mover last session, as the company saw its shares rise more than 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 31.4% in the past one-month time frame

The company has not seen any estimate revision change over the past few weeks, while the Zacks Consensus Estimate for the current quarter has remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Athersys currently has a Zacks Rank 2 (Buy) while its Earnings ESP is 0.00%.

Athersys, Inc. Price

Athersys, Inc. Price | Athersys, Inc. Quote

ADVERTISEMENT

Another stock worth considering in the Medical sector is Akari Therapeutics, Plc AKTX which carries a Zacks Rank #1 (Strong Buy).You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ATHX going up? Or down? Predict to see what others think: Up or Down

One Simple Trading Idea

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.

This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today.

Learn more >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Athersys, Inc. (ATHX) : Free Stock Analysis Report
 
Akari Therapeutics PLC (AKTX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research